|
C18ORF19 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.02060000345605E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.70250488654256E-11 |
| Normal-vs-Stage2 |
5.155200E-03 |
| Normal-vs-Stage3 |
8.146200E-02 |
| Normal-vs-Stage4 |
5.343800E-01 |
| Stage1-vs-Stage2 |
2.785400E-01 |
| Stage1-vs-Stage3 |
2.062000E-03 |
| Stage1-vs-Stage4 |
3.640100E-04 |
| Stage2-vs-Stage3 |
2.388400E-01 |
| Stage2-vs-Stage4 |
6.999700E-02 |
| Stage3-vs-Stage4 |
4.458200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.47190000082875E-08 |
| Normal-vs-AfricanAmerican |
1.682390E-01 |
| Normal-vs-Asian |
3.742000E-01 |
| Caucasian-vs-AfricanAmerican |
6.921900E-02 |
| Caucasian-vs-Asian |
9.937600E-01 |
| AfricanAmerican-vs-Asian |
4.925000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.164700E-04 |
| Normal-vs-Female |
6.46669995330029E-09 |
| Male-vs-Female |
2.083600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.736200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.74359999946827E-07 |
| Normal-vs-Age(61-80Yrs) |
4.30100000000655E-05 |
| Normal-vs-Age(81-100Yrs) |
9.680400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.828100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.533400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.086800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.104200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.362400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.583800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.155690E-02 |
| Normal-vs-Grade 2 |
4.76559902651275E-11 |
| Normal-vs-Grade 3 |
2.360900E-03 |
| Normal-vs-Grade 4 |
3.170200E-01 |
| Grade 1-vs-Grade 2 |
5.329600E-01 |
| Grade 1-vs-Grade 3 |
4.580100E-02 |
| Grade 1-vs-Grade 4 |
7.199800E-04 |
| Grade 2-vs-Grade 3 |
7.175200E-04 |
| Grade 2-vs-Grade 4 |
2.78109999474196E-08 |
| Grade 3-vs-Grade 4 |
4.301900E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.11022302462516E-16 |
| Normal-vs-ccB subtype |
2.277400E-01 |
| ccA subtype-vs-ccB subtype |
8.54999959720715E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.98586999999861E-05 |
| Normal-vs-N1 |
4.444200E-01 |
| N0-vs-N1 |
8.949200E-01 |
|
|
